Fleet

Manufacturer
C.B. Fleet Company, Inc.
Effective date
2025-06-23
Label type
HUMAN OTC DRUG LABEL
Version
6
Source
full-release
Hydrated at
2026-06-01 01:03:23

Label at a glance#

ProductFleet
Active ingredientBISACODYL
Label structure10 sections

Indications and uses

for relief of fecal impaction for relief of occasional constipation for removal of residue after barium administration This product usually produces a bowel movement in 5 to 20 minutes.

Dosage and administration

Single Daily Dosage (per 24 hours) adults and children 12 years and over 1 bottle per day children under 12 years DO NOT USE

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Purpose

OTC - PURPOSE SECTION

Bisacodyl 10 mg .............Stimulant laxative/ bowel cleanser

Uses

INDICATIONS & USAGE SECTION

  • for relief of fecal impaction
  • for relief of occasional constipation
  • for removal of residue after barium administration

This product usually produces a bowel movement in 5 to 20 minutes.

Warnings

WARNINGS SECTION

For rectal use only.

Do not use

OTC - DO NOT USE SECTION

when abdominal pain, nausea, or vomiting are present unless directed by a doctor.

Ask a doctor before using this product if you

OTC - ASK DOCTOR SECTION

  • have a sudden change in bowel habits lasting more than 2 weeks
  • already used a laxative for more than 1 week

This product may cause abdominal discomfort, faintness, rectal burning, and mild cramps.

Stop use and ask a doctor if you have

OTC - STOP USE SECTION

      • rectal bleeding

      • no bowel movement within 20 minutes of using this product.

These symptoms may indicate a serious condition.

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use. 

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

Single Daily Dosage (per 24 hours)

adults and children 12 years and over 1 bottle per day
children under 12 years DO NOT USE

Other information

OTHER SAFETY INFORMATION

• store at temperatures not above 86˚ F (30˚ C)

Inactive ingredients

INACTIVE INGREDIENT SECTION

carbomer 934P, glycerin, methylparaben, octoxynol-9, propylparaben, purified water, sodium hydroxide

Questions?

OTC - QUESTIONS SECTION

or www.fleetlabs.com

Tamper Evident: bottle sealed for safety. If bottle wrapper with fleet emblem is torn, damaged or missing, do not use.

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Fleet
Laxative
bisacodyl
Enema

PRINCIPAL DISPLAY PANEL Fleet Laxative bisacodyl EnemaPRINCIPAL DISPLAY PANEL Fleet Laxative bisacodyl Enema

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Fleet
Laxative
bisacodyl
Enema

PRINCIPAL DISPLAY PANEL Fleet Laxative bisacodyl EnemaPRINCIPAL DISPLAY PANEL Fleet Laxative bisacodyl Enema

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
308749bisacodyl 10 MG in 30 mL EnemaPSN6
308749bisacodyl 0.333 MG/ML EnemaSCD6
308749bisacodyl 10 MG per 30 ML EnemaSY6

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
DEACETYLBISACODYL Pharmacologic Class Indexing2Indexing - Pharmacologic Class20181113

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
e2db08c6-133f-4f4f-afb4-e90a2418d6f6Product name120230320
11ed6f83-cdd2-4637-8379-b1a1d3ae3cdeProduct name120181101
86c45a79-b9f0-4476-a27c-6e10db098497Product name120180125
89dac932-b90a-4410-9ab1-84c53e57de25Product name120150316

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0132-0703-36Fleet37 mL in 1 BOTTLE, WITH APPLICATORENEMA376

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0132-0703-36ML - Milliliter0132-07036603d126-4f4d-45f8-8bb8-ef133709514d12012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
BisacodylACTIVE INGREDIENT10X0709Y6I3
BisacodylACTIVE MOIETY10X0709Y6I3
CARBOMER HOMOPOLYMER TYPE BINACTIVE INGREDIENTHHT01ZNK313
GLYCERININACTIVE INGREDIENTPDC6A3C0OX3
METHYLPARABENINACTIVE INGREDIENTA2I8C7HI9T3
OCTOXYNOL 9INACTIVE INGREDIENT7JPC6Y25QS3
PROPYLPARABENINACTIVE INGREDIENTZ8IX2SC1OH3
SODIUM HYDROXIDEINACTIVE INGREDIENT55X04QC32I3
WATERINACTIVE INGREDIENT059QF0KO0R3

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
0132-07030132-0703-36

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 8 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 48 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
CARBOMER HOMOPOLYMER TYPE BCARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)HHT01ZNK31SOLUTION / TOPICAL11 mgExact identifier — unii candidate
34 equally ranked IID candidates
CARBOMER HOMOPOLYMER TYPE BCARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)HHT01ZNK31OINTMENT / TOPICAL11 mgExact identifier — unii candidate
34 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IENEMA / RECTAL0.44 %v/vExact identifier — unii+route+dosage form
2 equally ranked IID candidates
CARBOMER HOMOPOLYMER TYPE BCARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)HHT01ZNK31SUSPENSION/ DROPS / OPHTHALMIC0.45 %w/vExact identifier — unii candidate
34 equally ranked IID candidates
OCTOXYNOL 9OCTOXYNOL-97JPC6Y25QSSPONGE / TOPICAL5 %w/wExact identifier — unii candidate
6 equally ranked IID candidates
OCTOXYNOL 9OCTOXYNOL-97JPC6Y25QSSPONGE / TOPICAL5 %w/wExact identifier — unii candidate
6 equally ranked IID candidates
CARBOMER HOMOPOLYMER TYPE BCARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)HHT01ZNK31SUSPENSION / ORAL64 mgExact identifier — unii candidate
34 equally ranked IID candidates
CARBOMER HOMOPOLYMER TYPE BCARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)HHT01ZNK31SUSPENSION/ DROPS / OPHTHALMIC0.45 %w/vExact identifier — unii candidate
34 equally ranked IID candidates
CARBOMER HOMOPOLYMER TYPE BCARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)HHT01ZNK31SUSPENSION/ DROPS / TOPICAL0.4 %w/vExact identifier — unii candidate
34 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TENEMA / RECTAL0.18 %w/vExact identifier — unii+route+dosage form
2 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHENEMA / RECTAL0.02 %w/wExact identifier — unii+route+dosage form
2 equally ranked IID candidates
CARBOMER HOMOPOLYMER TYPE BCARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)HHT01ZNK31LOTION / TOPICAL0.3 %w/wExact identifier — unii candidate
34 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IENEMA / RECTAL0.44 %v/vExact identifier — unii+route+dosage form
2 equally ranked IID candidates
CARBOMER HOMOPOLYMER TYPE BCARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)HHT01ZNK31TABLET / ORAL8 mgExact identifier — unii candidate
34 equally ranked IID candidates
CARBOMER HOMOPOLYMER TYPE BCARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)HHT01ZNK31GEL / TRANSDERMAL19 mgExact identifier — unii candidate
34 equally ranked IID candidates
CARBOMER HOMOPOLYMER TYPE BCARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)HHT01ZNK31GEL / OPHTHALMIC2 mgExact identifier — unii candidate
34 equally ranked IID candidates
CARBOMER HOMOPOLYMER TYPE BCARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)HHT01ZNK31LOTION / TOPICAL0.3 %w/wExact identifier — unii candidate
34 equally ranked IID candidates
OCTOXYNOL 9OCTOXYNOL-97JPC6Y25QSGEL / TOPICAL2 mgExact identifier — unii candidate
6 equally ranked IID candidates
CARBOMER HOMOPOLYMER TYPE BCARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)HHT01ZNK31TABLET / BUCCAL19 mgExact identifier — unii candidate
34 equally ranked IID candidates
CARBOMER HOMOPOLYMER TYPE BCARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)HHT01ZNK31TABLET, EXTENDED RELEASE / ORAL180 mgExact identifier — unii candidate
34 equally ranked IID candidates
CARBOMER HOMOPOLYMER TYPE BCARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)HHT01ZNK31GEL / TRANSDERMAL19 mgExact identifier — unii candidate
34 equally ranked IID candidates
OCTOXYNOL 9OCTOXYNOL-97JPC6Y25QSGEL / TOPICAL2 mgExact identifier — unii candidate
6 equally ranked IID candidates
OCTOXYNOL 9OCTOXYNOL-97JPC6Y25QSLOTION / TOPICAL5 mgExact identifier — unii candidate
6 equally ranked IID candidates
CARBOMER HOMOPOLYMER TYPE BCARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)HHT01ZNK31OINTMENT / TOPICAL11 mgExact identifier — unii candidate
34 equally ranked IID candidates
CARBOMER HOMOPOLYMER TYPE BCARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)HHT01ZNK31GEL / TOPICAL81 mgExact identifier — unii candidate
34 equally ranked IID candidates
OCTOXYNOL 9OCTOXYNOL-97JPC6Y25QSLOTION / TOPICAL5 mgExact identifier — unii candidate
6 equally ranked IID candidates
CARBOMER HOMOPOLYMER TYPE BCARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)HHT01ZNK31TABLET / ORAL8 mgExact identifier — unii candidate
34 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TENEMA / RECTAL0.18 %w/vExact identifier — unii+route+dosage form
2 equally ranked IID candidates
CARBOMER HOMOPOLYMER TYPE BCARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)HHT01ZNK31SUSPENSION / OPHTHALMIC1 mgExact identifier — unii candidate
34 equally ranked IID candidates
CARBOMER HOMOPOLYMER TYPE BCARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)HHT01ZNK31SUSPENSION / OPHTHALMIC1 mgExact identifier — unii candidate
34 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSUPPOSITORY / RECTAL440 mgExact identifier — unii+route
2 equally ranked IID candidates
CARBOMER HOMOPOLYMER TYPE BCARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)HHT01ZNK31GEL / TOPICAL81 mgExact identifier — unii candidate
34 equally ranked IID candidates
CARBOMER HOMOPOLYMER TYPE BCARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)HHT01ZNK31SOLUTION / TOPICAL11 mgExact identifier — unii candidate
34 equally ranked IID candidates
CARBOMER HOMOPOLYMER TYPE BCARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)HHT01ZNK31CAPSULE / ORAL50 mgExact identifier — unii candidate
34 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSUPPOSITORY / RECTAL440 mgExact identifier — unii+route
2 equally ranked IID candidates
CARBOMER HOMOPOLYMER TYPE BCARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)HHT01ZNK31TABLET / BUCCAL19 mgExact identifier — unii candidate
34 equally ranked IID candidates
CARBOMER HOMOPOLYMER TYPE BCARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)HHT01ZNK31GEL / VAGINAL200 mgExact identifier — unii candidate
34 equally ranked IID candidates
CARBOMER HOMOPOLYMER TYPE BCARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)HHT01ZNK31SUSPENSION/ DROPS / TOPICAL0.4 %w/vExact identifier — unii candidate
34 equally ranked IID candidates
CARBOMER HOMOPOLYMER TYPE BCARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)HHT01ZNK31SUSPENSION / ORAL64 mgExact identifier — unii candidate
34 equally ranked IID candidates
CARBOMER HOMOPOLYMER TYPE BCARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)HHT01ZNK31CREAM / TOPICAL214 mgExact identifier — unii candidate
34 equally ranked IID candidates
CARBOMER HOMOPOLYMER TYPE BCARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)HHT01ZNK31GRANULE, FOR SUSPENSION / ORAL600 mgExact identifier — unii candidate
34 equally ranked IID candidates
CARBOMER HOMOPOLYMER TYPE BCARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)HHT01ZNK31TABLET, EXTENDED RELEASE / ORAL180 mgExact identifier — unii candidate
34 equally ranked IID candidates
CARBOMER HOMOPOLYMER TYPE BCARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)HHT01ZNK31CREAM / TOPICAL214 mgExact identifier — unii candidate
34 equally ranked IID candidates
CARBOMER HOMOPOLYMER TYPE BCARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)HHT01ZNK31GRANULE, FOR SUSPENSION / ORAL600 mgExact identifier — unii candidate
34 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHENEMA / RECTAL0.02 %w/wExact identifier — unii+route+dosage form
2 equally ranked IID candidates
CARBOMER HOMOPOLYMER TYPE BCARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)HHT01ZNK31CAPSULE / ORAL50 mgExact identifier — unii candidate
34 equally ranked IID candidates
CARBOMER HOMOPOLYMER TYPE BCARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)HHT01ZNK31GEL / OPHTHALMIC2 mgExact identifier — unii candidate
34 equally ranked IID candidates
CARBOMER HOMOPOLYMER TYPE BCARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)HHT01ZNK31GEL / VAGINAL200 mgExact identifier — unii candidate
34 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
FleetBISACODYLC.B. Fleet Company, Inc.324e61eb-8f6b-48d7-85c2-b1b5642691c92025-06-23WarningsExact identifier
ndc (package): 0132-0703-36
ndc (product): 0132-0703
ndc11 (package): 00132070336
spl id: 40f1280a-905c-465d-a9bd-271b92e333f2
spl set id: 324e61eb-8f6b-48d7-85c2-b1b5642691c9

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.